Company Filing History:
Years Active: 1986-1993
Title: Ray W Fuller: Innovator in Pharmaceutical Chemistry
Introduction
Ray W Fuller is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the development of compounds that impact serotonin uptake, which is crucial in treating various mental health conditions.
Latest Patents
Among his latest patents, one notable invention is (S)-norfluoxetine, which is designed to inhibit serotonin uptake. This invention provides (S)-norfluoxetine and pharmaceutically acceptable salts capable of effectively inhibiting the uptake of serotonin. Another significant patent is for 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate, which outlines a method of blocking 5HT without affecting alpha receptors using 1-loweralkyl-6-straight chain alkyl-8.beta.-hydroxycycloalkyloxycarbonylergolines.
Career Highlights
Ray W Fuller is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to advancements in medication that improve patient outcomes.
Collaborations
Throughout his career, Ray has collaborated with esteemed colleagues, including Marlene L Cohen and William L Garbrecht. These collaborations have fostered an environment of innovation and have led to the successful development of several pharmaceutical products.
Conclusion
Ray W Fuller exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations continue to impact the field positively. His work at Eli Lilly and Company highlights the importance of research in developing effective treatments for mental health conditions.